Home > Insider Trading > Filing (0001567619-21-016864)

Filing Details

Accession Number:: 0001567619-21-016864
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2021-09-08 19:37:57
Reporting Period:: 2021-09-07

Accepted Time:: 2021-09-08 19:37:57
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
722723	Hanger Inc.	HNGR	Services-Specialty Outpatient Facilities, Nec (8093)	840904275

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1454324	K Vinit Asar	10910 Domain Drive Suite 300 Austin TX 78758	President And Ceo	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2021-09-07	14,900	$22.04	753,319	No	4	S	Direct
Common Stock	Disposition	2021-09-07	100	$23.09	753,219	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct
No	4	S	Direct

Reported Derivative Holdings

Show Other Fields >>

Sec. Name	Sec. Type	Price	Date	Expiration Date	Amount	Remaning Holdings	Nature of Ownership
Common Stock	Stock Options (right to buy)	$12.77		2027-05-19	159,982	159,982	Direct

Expiration Date	Amount	Remaning Holdings	Nature of Ownership
2027-05-19	159,982	159,982	Direct

Footnotes

The sales by Mr. Asar were effected automatically upon the satisfaction of certain timing, trading price and other conditions under a trading plan designed to comply with Rule 10b5-1 of the Securities Exchange Act of 1934. Mr. Asar entered into this trading plan on December 4, 2020 and up to 15,000 additional shares could be sold through periodic sales that may occur under this plan through the end of 2021 if the conditions of the plan are met.
These shares were sold at a range of sale prices from $21.76 to $22.59. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
Includes (i) unvested restricted shares totaling 55,791 shares of stock from an initial grant of 55,791 shares of restricted stock which begins to vest on March, 8, 2022; (ii) unvested restricted shares totaling 62,847 shares of stock from an initial grant of 69,705 shares of restricted stock which begins to vest on March 9, 2021; (iii) unvested restricted shares totaling 49,292 shares of stock from an initial grant of 54,670 shares of restricted stock which begins to vest on March 9, 2021; (iv) unvested restricted shares and fully vested shares totaling 59,429 shares of stock from an initial grant of 73,987 shares of restricted stock made on March 8, 2019; [continued in next footnote]
(v) unvested restricted shares and fully vested shares totaling 46,954 shares of stock from an initial grant of 58,456 shares of restricted stock made on March 8, 2019; (vi) unvested restricted shares and fully vested shares totaling 56,786 shares of stock from an initial grant of 80,564 shares of restricted stock made on March 9, 2018; (vii) unvested restricted shares and fully vested shares totaling 57,312 shares of stock from an initial grant of 94,500 shares of restricted stock, 25% of which vested on May 17, 2018 and the remainder of which vested on March 8, 2019, 2020 and 2021 (viii) unvested restricted shares and fully vested shares totaling 38,188 shares of stock from an initial grant of 60,000 shares of restricted stock made on April 29, 2016; [continued in next footnote]
(ix) unvested restricted shares and fully vested shares totaling 47,590 shares of stock from an initial grant of 67,516 shares of restricted stock made on March 9, 2018; (x) fully vested shares totaling 65,566 shares of stock from an initial grant of 95,376 shares of restricted stock made on March 6, 2015; (xi) unvested restricted shares and fully vested shares totaling 36,388 shares of stock from an initial grant of 60,000 shares of restricted stock made on March 8, 2017 (xii) fully vested shares totaling 32,807 shares of stock from an initial grant of 42,390 shares of restricted stock made on March 6, 2015; [continued in next footnote]
(xiii) fully vested shares totaling 13,746 shares of stock from an initial grant of 17,973 shares of restricted stock made on March 7, 2014; (xiv) fully vested shares totaling 17,963 shares of stock from an initial grant of 29,292 shares of restricted stock and performance shares made on March 11, 2013; (xv) fully vested shares totaling 9,917 shares of stock from an initial grant of 17,250 shares of restricted stock and performance shares made on August 27, 2012; (xvi) fully vested shares totaling 15,868 shares of stock from an initial grant of 27,600 shares of restricted stock and performance shares made on March 7, 2012; [continued in next footnote]
(xvii) fully vested shares totaling 4,712 shares of stock from an initial grant of 15,923 shares of restricted stock and performance shares made on March 25, 2011; and (xviii) fully vested shares totaling 22,270 shares of stock from an initial grant of 42,680 shares of restricted stock and performance shares made on December 29, 2008.
Except as otherwise noted, all remaining unvested restricted shares will continue to vest at a rate of 25% per year of the original grant amount on the anniversary date of the grant.
Stock options were granted under the Company's Special Equity Plan and vest 1/3 on each of May 19, 2018, 2019 and 2020.